stockrowQIAGEN N.V. (QGEN) vs RadNet, Inc. (RDNT)
- QIAGEN N.V. QGEN 50.88 +0.10%
- RadNet, Inc. RDNT 78.45 −2.26%
QIAGEN N.V. and RadNet, Inc. are both Diagnostics & Research companies. QIAGEN N.V. is the larger, with a market value of $10.5B against $6.1B — 1.7× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; QIAGEN N.V. trades at 26.1×. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs −0.93%) and the higher return on invested capital (6.62% vs 2.24%). Across the 21 metrics below, QIAGEN N.V. leads on 17 and RadNet, Inc. on 4.
Valuation
Profitability
| Metric | QGEN | RDNT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 62.20% | 11.53% | 48.32% |
| Operating margin | 21.21% | 3.12% | (5.68%) |
| Net margin | 19.49% | (0.93%) | (4.10%) |
| Free cash flow margin | 20.98% | 3.28% | 0.00% |
| Return on equity | 11.93% | (1.64%) | 0.00% |
| Return on assets | 6.99% | (0.55%) | (6.05%) |
| Return on invested capital | 6.62% | 2.24% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack